Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HEL/HRTIS stock hub

HEL/HRTIS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HEL/HRTISis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

47.5M

Nasdaq Helsinki

Market data

Price

Recent price action with selectable time range.

HEL/HRTISHEL/HRTIS

—

Loading chart…

In the news

Latest news · HEL/HRTIS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HEL/HRTIS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

EUR

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Employees	13
Employees Change	2%
Employees Change Percent	18.18
Enterprise value	EUR 45M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FI4000087861
Last refreshed	2026-05-10
Market cap	EUR 47.5M
Price	EUR 1.79
Price currency	EUR
Sector	Healthcare
Sic	2834
Symbol	hel/HRTIS
Website	https://herantis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.94%
EV Earnings	-6.79x
P/B ratio	-28.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -6.6M
Net Income Growth Years	0%
Profit Per Employee	EUR -509,242
ROA	-152.6
Roa5y	-70.87
ROCE	-364.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.29%
Cagr1y	33.76%
Cagr3y	-4.85%
Cagr5y	-5.87%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 2.7M
Cash	EUR 2.6M
Current Assets	EUR 2.7M
Current Liabilities	EUR 912,993
Debt	EUR 69,182
Equity	EUR -1.7M
Interest Coverage	-465.3
Liabilities	EUR 4.4M
Long Term Assets	EUR 0
Long Term Liabilities	EUR 3.4M
Net Cash	EUR 2.5M
Net Cash By Market Cap	EUR 5.32
Net Cash Growth	20.1%
Tangible Book Value	EUR -1.7M
Tangible Book Value Per Share	EUR -0.07
WACC	7.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.92
Net Working Capital	EUR -792,173
Quick ratio	2.88
Working Capital	EUR 1.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	121.67%
1Y total return	33.73%
200-day SMA	2
3Y total return	-13.85%
50-day SMA	1.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-26.11%
All Time High	11
All Time High Change	-83.71%
All Time High Date	2014-06-11
All Time Low	0.77
All Time Low Change	134.25%
All Time Low Date	2016-07-18
ATR	0.11
Beta	0.63
Beta1y	0.34
Beta2y	-0.04
Ch YTD	-12.16
High	1.85
High52	3.87
High52 Date	2025-10-08
High52ch	-53.7%
Low	1.78
Low52	1.22
Low52 Date	2025-06-12
Low52ch	46.89%
Ma50ch	-1.05%
Price vs 200-day SMA	-10.4%
RSI	52.46
RSI Monthly	49.51
RSI Weekly	44.27
Sharpe ratio	0.69x
Sortino ratio	1.23
Total Return	-17.23%
Tr YTD	-12.16
Tr1m	13.56%
Tr1w	2.64%
Tr3m	-22.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -6.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,836,208%
Net Borrowing	1,262,595
Shares Insiders	13.82%
Shares Institutions	40.02%
Shares Out	26,503,817
Shares Qo Q	-3.82%
Shares Yo Y	17.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	26,929.35x
Bv Per Share	-0.07
Ch10y	110.8
Ch1m	13.56
Ch1w	2.64
Ch1y	33.73
Ch3m	-22.76
Ch3y	-13.85
Ch5y	-29.73
Ch6m	-17.8
Change	1.24%
Change From Open	-3.24
Close	1.77
Days Gap	4.63
Dollar Volume	49,018.4
Earnings Date	2026-08-20
EBIT	EUR -6.4M
EPS	EUR -0.28
F Score	2
Financing CF	6,455,585
Fiscal Year End	December
Founded	2,008
Investing CF	-243,782
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Ma150	2.07
Ma150ch	-13.43%
Ma20	1.75
Ma20ch	2.58%
Net CF	116,478
Next Earnings Date	2026-08-20
Open	1.85
Position In Range	16.22
Price Date	2026-05-08
Relative Volume	1.04x
Tr6m	-17.8%
Volume	27,354

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HEL/HRTIS pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/HRTIS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HEL/HRTIS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.0%

Share of float held by funds and institutions

Insider ownership

+13.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.2%

Negative means the company is buying back shares.

Technical

HEL/HRTIS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.5

Neutral momentum band

Price vs 200-day MA

-10.4%

50/200-day relationship not available

Beta (5Y)

0.63

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HEL/HRTIS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/HRTIS stock rating?

hel/HRTIS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/HRTIS analysis?

The full report lives at /stocks/hel/HRTIS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/HRTIS?

The latest report frames hel/HRTIS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/HRTIS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.